Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA

Nov 02, 2007, 01:00 ET from Biomist Inc.

    PARK RIDGE, Ill., Nov. 2 /PRNewswire/ -- The recent surge in
 Methicillin-resistant Staphylococcus aureus (MRSA) cases have thrust the
 infection into the spotlight. Most commonly traced to health care
 environments (HA-MRSA), the new community acquired (CA-MRSA) strains are
 now being found in schools, universities and athletic settings(1).
 Hospitals concerned about the growing incidence of "superbugs" such as MRSA
 are turning to a new technology that converts alcohol into a nonflammable
 vapor, making it possible to sanitize surfaces that cannot be quickly
 sanitized by other methods.
     This new system utilizes liquid carbon dioxide as a propellant to spray
 a fine alcohol mist. Using this process, oxygen is temporarily displaced by
 an envelope of rapidly expanding CO2 gas, rendering the vapor nonflammable.
 The technology, known as NAV-CO2, has recently stepped into the spotlight
 following the diagnosis of MRSA in previously healthy teens and young
 adults. CA-MRSA is becoming more prevalent in school, university and
 athletics environments.
     "What makes NAV-CO2 technology unique is that it is non-corrosive,
 self-drying, and safe on almost all materials" says Robert Cook, of Biomist
 Inc., a company based in Park Ridge, Illinois. "The ease of use allows one
 person to effectively sanitize over 4000 square feet in under two hours.
 The vapor penetrates into cracks and crevices where pathogens hide, and
 disinfects areas beyond physical reach. For example, you can sanitize
 between the keys on a laptop and kill pathogens without corrosion. This is
 not possible with a spray bottle of bleach and a rag."
     "Veterans Administration hospitals are leading the way in U.S. MRSA
 prevention" says Charles Carman, a management consultant working with
 hospitals on infection prevention. "The difference is the leadership. VA
 Hospitals have made combating MRSA a priority, and have made investments in
 NAV-CO2 systems. Ultimately, VA Hospitals will recover the investment many
 times over in labor savings and achieve a hygienic environment for
 patients, visitors and staff."
     For more information, call 847-803-1720 or log on to
     1. Stemper ME, Brady JM, Qutaishat SS, Borlaug G, Reed J, Reed KD, et
     Shift in Staphylococcus aureus clone linked to an infected tattoo.
     Emerg Infect Dis [serial on the Internet]. 2006 Sep [date cited].
        Available from
     Media Contact: Robert Cook
     Phone: (847) 803-1720

SOURCE Biomist Inc.